LEO Pharma thrombosis business unit executive vice-president Jean Monin stated: “We are excited to partner with Junshi Biosciences, supplementing LEO Pharma’s Thrombosis business, which ...

Jean Monin, Executive Vice President of Thrombosis Business Unit, LEO Pharma, commented, “We are excited to partner with Junshi Biosciences, supplementing LEO Pharma’s Thrombosis business ...

Leo Pharma has established a mature distribution network and rich marketing expertise in the local markets.” Jean Monin, executive vice president of the thrombosis business unit at Leo ...

(RTTNews) - Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule oral STAT6 (signal transducer and activator of ...

Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to distribute and market the monoclonal antibody, toripalimab, in Europe.

Jean Monin, Executive Vice President of Thrombosis Business Unit, LEO Pharma, commented, "We are excited to partner with Junshi Biosciences, supplementing LEO Pharma's Thrombosis business, which ...

Under the agreement, LEO Pharma will be responsible for toripalimab’s distribution, promotion, sales, etc., in up to 32 countries, including all member states of the European Union (EU ...

Under the agreement, LEO Pharma will be responsible for toripalimab’s distribution, promotion, sales, etc., in up to 32 countries, including all member states of the European Union (EU) and the ...